CHEMED CORP (CHE) research
CHEMED CORP- Sector
- Health Care
- Last price
- $499.82
- As of
Kresmion compiles this page from CHE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CHEMED CORP (CHE): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-31.
As of . Source: SEC EDGAR filings for CHE. Method and limitations.
Share the CHE intelligence card
See the full CHE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CHE on one page. Preview it with sample data, then open it live with a free account.
Preview the CHE dossierActive signals for CHE
- highCONSENSUS_SELL
4 tracked funds reduced CHE this 2026Q2, institutional consensus
- highCONSENSUS_BUY
4 tracked funds increased CHE this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1322% to CHE (2026Q2)
- highCONSENSUS_SELL
3 tracked funds reduced CHE this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased CHE this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every signal on CHE, as it fires
You are seeing 5 of 17 signals recorded on CHE since 2026-05-16.
The five above landed across 2 days. The other 12 were recorded on 3 other days. 9 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CHE (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 16359R103 · 2026Q2 | $34.7M | 0.04% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 16359R103 · 2026Q2 | $23.5M | 0.01% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 16359R103 · 2026Q2 | $18.2M | 0.03% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 16359R103 · 2026Q2 | $10.4M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 16359R103 · 2026Q2 | $9.5M | 0.04% | , |
| D. E. Shaw & Co., Inc.CUSIP 16359R103 · 2026Q2 | $2.9M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CHE
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CHE against its peers
CHE's operating margin of 13.4% ranks in the 72nd percentile of 22 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | CHE | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.5B USD | 1.5B USD | 67 | 25 |
| Gross margin | n/a | 60.1% | n/a | 18 |
| Operating margin | 13.4% | 7.0% | 72 | 22 |
| Net margin | 10.5% | 3.6% | 83 | 25 |
| Return on equity | 27.1% | 8.1% | 94 | 25 |
| P / E | 27.3x | 38.5x | 21 | 16 |
Peers (25): LNTH, PACS, HIMS, RDNT, DOCS, HAE, TFX, MMSI, HNGE, WAY, OPCH, MASI, GKOS, ITGR, ENSG, LIVN, MOH, CRVL, NVST, IRTC, EHC, PEN, BTSG, ATRC, ACHC. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (CHE: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CHE on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CHE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.